Medpace Holdings (MEDP) EV to EBITDA (2016 - 2026)

Medpace Holdings (MEDP) has reported EV to EBITDA for 11 consecutive years, with 93.09 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EV to EBITDA rose 41.3% year-over-year to 93.09; the trailing twelve-month figure through Jun 2026 stood at 23.39 (up 34.77% YoY), and the FY2025 full-year result was 27.46, up 37.12% from the prior year.
• EV to EBITDA climbed to 93.09 in Q2 2026 per MEDP's latest filing, from 88.1 in the prior quarter.
• Across five years, EV to EBITDA topped out at 109.44 in Q1 2024 and bottomed at 58.67 in Q3 2022.
• Historically, EV to EBITDA has averaged 83.3 across 5 years, with a median of 81.03 in 2022.
• The sharpest annual moves came in 2022 and 2024: EV to EBITDA slumped 47.08% in 2022, then soared 75.53% in 2024.
• Over 5 years, EV to EBITDA stood at 80.68 in 2022, then climbed by 21.39% to 97.94 in 2023, then retreated by 26.75% to 71.74 in 2024, then soared by 34.34% to 96.37 in 2025, then fell by 3.4% to 93.09 in 2026.
• According to Business Quant data, EV to EBITDA over the past three periods registered 93.09, 88.1, and 96.37 for Q2 2026, Q1 2026, and Q4 2025 respectively.